Ameriprise
LAB icon

Ameriprise’s Standard BioTools LAB Stock Holding History

Ameriprise’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,910
Closed -$72K – 4011
2021
Q3 		$72K Sell
10,910
-400
-4% -$2.63K ﹤0.01% 3801
2021
Q2 		$70K Hold
11,310
– – ﹤0.01% 3846
2021
Q1 		$51K Sell
11,310
-90
-0.8% -$494 ﹤0.01% 3800
2020
Q4 		$69K Sell
11,400
-18,445
-62% -$121K ﹤0.01% 3709
2020
Q3 		$222K Buy
29,845
+19,240
+181% +$133K ﹤0.01% 3511
2020
Q2 		$42K Buy
+10,605
New +$36.9K ﹤0.01% 3623
2016
Q1 		– Sell
-106,861
Closed -$1.16M – 3818
2015
Q4 		$1.16M Buy
+106,861
New +$1.05M ﹤0.01% 2884
2014
Q4 		– Sell
-55
Closed -$1K – 4087
2014
Q3 		$1K Buy
55
+15
+38% +$422 ﹤0.01% 5555
2014
Q2 		$1K Sell
40
-16
-29% -$513 ﹤0.01% 5351
2014
Q1 		$2K Buy
56
+16
+40% +$704 ﹤0.01% 5054
2013
Q4 		$2K Sell
40
-1,585
-98% -$46.7K ﹤0.01% 4881
2013
Q3 		$36K Buy
1,625
+40
+3% +$786 ﹤0.01% 4010
2013
Q2 		$28K Buy
+1,585
New +$27.8K ﹤0.01% 4075

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return